Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-21-046888)

Filing Details

Accession Number:: 0000899243-21-046888
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-06 08:12:01
Reporting Period:: 2021-12-02

Accepted Time:: 2021-12-06 08:12:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1840574	Verve Therapeutics Inc.	VERV	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1573163	D. Andrew Ashe	C/O Verve Therapeutics, Inc. 500 Technology Square, Suite 901 Cambridge MA 02139	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-12-02	4,000	$32.10	170,722	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $31.93 to $32.12 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.